No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Piper Sandler Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $20
Piper Sandler Remains a Buy on Solid Biosciences (SLDB)
Solid Biosciences to Participate at Upcoming Investor Conferences
Solid Biosciences Advances Gene Therapy Pipeline
Express News | Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Express News | Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors